The startup’s celebrated co-founder is Daniel Ek, the CEO and driving force behind digital music giant Spotify.

Radiology that facilitates the sharing of resources and touchpoints within an enterprise but across geographic locales is the future of the specialty, according to two Harvard radiology researchers.

A therapeutic oncology company has been cleared to market a cancer treatment that that turns a tumor’s own biology into a self-signaling target for radiation therapy.

Whatever specific shape work takes in the near and distant future, it’s likely the COVID-19 era will be looked back upon as a before-and-after dividing line.

Clarius Mobile Health of Vancouver, B.C., has won FDA approval to market an AI model that works with the company’s handheld point-of-care ultrasound devices to identify and measure tendons of the foot, ankle and knee.

Instagram is a fairly close second, Facebook a fighting third, Twitter a respectable fourth and LinkedIn a visible fifth.

The FDA has cleared U.K.-based Adaptix to market a 3D X-ray system that, according to the company, images hands, feet and elbows “at a fraction of the radiation dose and per-study cost of traditional CT.”

GE HealthCare has some favorable tailwinds at its back as it proceeds into its first year unattached to a certain venerable parent corporation.